With the rapid advancements in digital technologies over the last few decades, the way we communicate with one another has changed dramatically in recent years. Especially, email, social media, and mobile proximity have completely transformed our day-to-day conversations with family, friends, colleagues, and customers. Twenty or 30 years ago, communicating with a client in another city or country would primarily occur over landlines – and only if the client was in proximity of their phone, would they be able to answer. Today, we can send a two-sentence email or instant message and get a reply right away or whenever convenient for the other person. However, despite all of its advantages, the increasing reliance on digital technologies for communicating and collaborating also comes with some downsides.
In the first part of this eBook, I discuss the pros and cons of digitalization, focusing specifically on mobile knowledge collaboration, how to manage digital overwhelm, and social networks as the new digital currency.
In the second part, I take it one step further and discuss how digital technologies now play major roles in healthcare through the facilitation of collection of big data and the development of digital health tools and neurotechnologies. Finally, I touch upon the importance of behavioral science and behavioral marketing in the digital age.
There is no doubt that digital technologies and collaboration platforms, when used in a way that will improve productivity and effectiveness (and not the other way around) are essential for the success of any endeavor. This is particularly true for pharma, life science, and biotechnology companies looking to keep up or stay ahead of the competition. Digital tools, along with appropriate use of data and behavioral sciences, will be key not only for research purposes, but also for designing marketing strategies and making sure that the product or service reaches its target audience, ultimately improving the health of the patients. Furthermore, digital collaboration will help facilitate both communication between internal stakeholders, as well as between pharma teams and their key opinion leaders.